Drug Search Results
More Filters [+]

Ecraprost

Alternative Names: ecraprost
Latest Update: 2006-05-19
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Mitsubishi Tanabe
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ecraprost

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Peripheral Vascular Diseases|Peripheral Arterial Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

WFI 01-01

P3

Terminated

Peripheral Vascular Diseases|Peripheral Arterial Disease

None

WFI 01-02

P3

Completed

Peripheral Arterial Disease|Peripheral Vascular Diseases

None

Recent News Events

Date

Type

Title